An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians - News release
Imperial College London News Release
Under embargo until
1800 UK time
Sunday 28 August 2011
An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians. The findings, published in Nature Genetics, give scientists new leads in the search for diagnostic markers and drug targets to prevent and treat this major disease.
- Nature Genetics
- Imperial Comprehensive Biomedical Research Centre
- Medical Research Council
- Wellcome Trust
Related news stories:
People of South Asian ancestry are up to four times more likely than Europeans to develop type 2 diabetes, which is a major risk factor for heart disease and stroke. Around 55 million South Asian people are affected worldwide, and the number is projected to rise to 80 million by 2030.
This new study is the first to focus on genes underlying diabetes amongst people originating from South Asia (India, Pakistan, Sri Lanka and Bangladesh). The researchers from around the world examined the DNA of 18,731 people with type 2 diabetes and 39,856 healthy controls. The genomes of the participants were analysed to look for locations where variations were more common in those with diabetes. The results identified six positions where differences of a single letter in the genetic code were associated with type 2 diabetes, suggesting that nearby genes have a role in the disease.
Dr John Chambers, the senior author of the study, from the School of Public Health at Imperial College London, said: "Type 2 diabetes is more common in South Asian populations than any other ethnic group, but the reason for this increased risk is unclear. Although lifestyle factors such as unhealthy diet, physical inactivity and obesity are important causes of diabetes in South Asians, these are only part of the explanation. Genetic factors have been widely considered to play a role in the increased risk of type 2 diabetes in Asians, but to date have not been systematically explored in this population."
"Our study identifies six new genetic variants linked to type 2 diabetes in South Asians. Our findings give important new insight into the genes underlying of diabetes in this population, which in the long term might lead to new treatments to prevent diabetes."
Professor Jaspal S Kooner, from the National Heart and Lung Institute at Imperial College London, the lead author for the study said: "This is the first genome-wide association study in South Asians, who comprise one-quarter of the globe's population, and who carry a high burden of the disease and its complications, including heart attack and stroke. We have shown that the genetic variants discovered here in South Asians also exist and contribute to diabetes in Europeans. Our studies in Asians and European populations highlight the importance and gain in examining the same problem in different ethnic groups."
The collaboration included leading researchers from Imperial College London, University of Oxford, University of Cambridge, the University of Birmingham, and the Peninsular Medical School in the UK, as well National University of Singapore, University of Mauritius, Baker IDI (Australia), Mohan Diabetes Centre (India), University of Kelaniya (Sri Lanka), NCGM (Japan), University of Houston (USA), Aga Khan University (Pakistan) and other institutions.
The research was funded by the Imperial Comprehensive Biomedical Research Centre award from the National Institute of Health Research; the Medical Research Council, the Wellcome Trust and other sources.
For further information please contact:
Research Media Officer
Imperial College London
Tel: +44(0)20 7594 2198
Out of hours duty press officer: +44(0)7803 886 248
Notes to editors:
1. Journal reference: J.S. Kooner et al. 'Genome-wide association study in people of South Asian ancestry identifies six novel susceptibility loci for type 2 diabetes.' Nature Genetics, 28 August 2011.
2. About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve global health, tackle climate change, develop sustainable sources of energy and address security challenges.
In 2007, Imperial College London and Imperial College Healthcare NHS Trust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them in to new therapies as quickly as possible.
3. About the Medical Research Council
For almost 100 years the Medical Research Council has improved the health of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including one of the first antibiotics penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century. www.mrc.ac.uk
4. About the Wellcome Trust
The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial int erests. Website: www.wellcome.ac.uk
Article text (excluding photos or graphics) available under an Attribution-NonCommercial-ShareAlike Creative Commons license.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Communications and Public Affairs